@ARTICLE{
author={Mateos Maria-Victoria,Szarejko Monika,Bila Jelena S,Schjesvold Fredrik,Spicka Ivan,Maisnar Vladimir,Jurczyszyn Artur,Grudeva-Popova Zhanet,Hajek Roman,Usenko Hanna,Thuresson Marcus,Norin Stefan,Jarefors Sara,Richardson Paul,Pour Ludek},
year={2023},
title={Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy},
journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA},
volume={23},
number={},
pages={S200-S201},
document_type={Meeting Abstract},
}